Correction

A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome

N Engl J Med 2003; 349:2577December 25, 2003

Article

A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome (Original Article, N Engl J Med 2003:349;1133 - 1138) . On page 1136, in Table 1, the number (percentage) of patients who had systemic lupus erythematosus in the group with a target international normalized ratio of 2.0 to 3.0 should have been 16 (28), rather than 6 (10), as printed, and the corresponding P value should have been 0.21, rather than 0.24, as printed.

Citing Articles (1)

Citing Articles

1. 1

   Philip G de Groot, Ronald H.W.M Derksen. (2004) Antiphospholipid antibodies: update on detection, pathophysiology, and treatment. Current Opinion in Hematology 11:3, 165-169
   CrossRef